课题基金 / 基金详情

CORE--CLINICAL, MOLECULAR GENETICS & DATA MANAGEMENT

CORE--CLINICAL, MOLECULAR GENETICS & DATA MANAGEMENT
核心——临床、分子遗传学
批准号:
6230122
负责人:
GEORGE F WOOTEN
金额:
$23.08万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-09-30 至 2004-07-31

项目摘要

项目成果

GEORGE F WOOTEN的其他基金

相似基金

相关文献

中文摘要
翻译
该中心的主要科学主题是阐明线粒体复合体I功能障碍在帕金森病(PD)发病机制和病理生理中的作用。帕金森病患者线粒体复合体I缺陷的存在现已得到充分证实。这种缺陷似乎是由于线粒体DNA (mtDNA)异常引起的,可能是遗传的,也可能是获得的。核心的目的是支持四个项目,旨在:1)PD受试者和对照组的mtDNA测序;2)研究帕金森病的线粒体结构和功能;3)阐明帕金森病的遗传病因;4)阐明线粒体功能障碍与神经元死亡的关系。为此目的,核心由四个相互作用和相互依存的部分组成:1)行政;(二)科目的发生与确定;III)分子遗传学;数据管理和生物统计学。行政部门(一)将监督中心的整个业务,并为所有四个项目以及中心的平衡提供服务。核心的受试者应计和确定部分(II)将累积并充分表征PD受试者。这一核心功能对所有四个项目都至关重要。多重家族的确定将服务于项目1和项目3,而核心功能是确定和验证受试者的家族史将直接服务于项目3,通过进一步表征mtDNA可能被纳入杂交体的受试者,间接服务于其他项目。分子遗传组件(III)将创建杂交以服务于项目1、2和4,筛选项目3中研究的受试者先前描述的与PD相关的核DNA突变,并对所有受试者和对照组进行核和线粒体DNA库。核心的数据管理和生物统计部分(四)将服务于所有四个项目;尤其是项目3,它提出了复杂的分离分析和其他性别对PD传播影响的统计遗传分析。
英文摘要
The main scientific theme of this Center is to elucidate the role of mitochondrial Complex I dysfunction in the pathogenesis and pathophysiology of Parkinson's disease (PD). The presence of a mitochondrial Complex I defect in subjects with PD is now well established. This defect appears to arise as a consequence of abnormalities in mitochondrial DNA (mtDNA) and may be either inherited or acquired. The purpose of the Core is to support four projects aimed at: 1) sequencing mtDNA in PD subjects and controls; 2) characterizing mitochondrial structure and function in PD; 3) clarifying the genetic etiology of PD; and 4) elucidating the relationship between mitochondrial dysfunction and neuronal death. To that end, the Core is composed of four interactive and interdependent components: I) Administration; II) Subject Accrual and Ascertainment; III) Molecular genetics; and IV) Data Management and Biostatistics. The Administration Component (I) will oversee the entire operation of the Center and will serve all four projects as well as the balance of the Core. The Subject Accrual and Ascertainment Component (II) of the Core will accrue and fully characterize subjects with PD. THIS Core function is essential for all four projects. The ascertainment of multiplex families will serve Projects 1 and 3, while the Core function is ascertaining and validating the family history of subjects will serve Project 3 directly and the other Projects indirectly by further characterizing the subjects whose mtDNA may be incorporated into cybrids. The Molecular Genetic Component (III) will create cybrids to serve Projects 1, 2, and 4, screen subjects studied in Project 3 for previously described nuclear DNA mutations associated with PD, and bank nuclear and mitochondrial DNA on all subjects and controls. The Data Management and Biostatistics Component (IV) of the Core will serve all four projects; but particularly Project 3 which proposes complex segregation analysis and other statistical genetic analyses of gender effects on transmission of PD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CORE--CLINICAL, MOLECULAR GENETICS & DATA MANAGEMENT
  • 批准号:
    6664104
  • 项目类别:
  • 资助金额:
    $23.19万
  • 财政年份:
    2002
  • 负责人:
    GEORGE F WOOTEN
  • 依托单位:
Parkinson's Disease Neuroprotection Clinical Trial
  • 批准号:
    6797316
  • 项目类别:
  • 资助金额:
    $2.96万
  • 财政年份:
    2002
  • 负责人:
    GEORGE F WOOTEN
  • 依托单位:
Parkinson's Disease Neuroprotection Clinical Trial
  • 批准号:
    6660782
  • 项目类别:
  • 资助金额:
    $10.88万
  • 财政年份:
    2002
  • 负责人:
    GEORGE F WOOTEN
  • 依托单位:
Parkinson's Disease Neuroprotection Clinical Trial
  • 批准号:
    7555448
  • 项目类别:
  • 资助金额:
    $4.72万
  • 财政年份:
    2002
  • 负责人:
    GEORGE F WOOTEN
  • 依托单位:
海外基金